All small-, mid-size or virtual pharma companies bringing a new biotech drug candidate through clinical trial will be challenged by a myriad of complex technical, regulatory and logistical obstacles on their journey to commercialization.
In this webinar experts from Sharp Clinical and Berkshire Sterile Manufacturing will outline the optimal flow in that process, from sterile manufacturing and filling of vials, cartridges and syringes through to packaging and distribution solutions for small-, mid-size and virtual pharma companies.
Attendees will receive an overview of the various multi-container, flex-fill options for product candidates and the unique advantages of utilising 100 per cent isolator technology, which removes the risk of human contamination from the filling and formulation process.
The speakers will discuss some of the complexities of shipping and distribution of clinical trial product, highlighting some of the potential risks — and the associated mitigations — to allow clinical professionals to plan the optimal movement of their temperature-controlled clinical supply.
This webinar will cover:
- An overview of the optimal flow of drug products from manufacture through to distribution
- Utilising a 100 per cent isolator sterile filling solution for drug products
- Multi-container options
- Flex-fill process overview
- Unique technical advantages
- The potential risks & mitigations faced in shipping & distributing temperature-controlled drug products such as:
- Transfer of materials under quarantine
- Supply chain custody
- Shipper and monitor qualifications
Distribution Manager, Sharp Clinical Services
CEO, Berkshire Sterile Manufacturing